Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma.
Yan S, Liu L, Zhang X, Wei L, Jiang W, Gao X, Yang A, Liu X, Chen W, Chen Y, Li H, Lin Q, Li M, Chen J, Zhang Q, Chen S, Song M.
Yan S, et al.
Clin Transl Oncol. 2024 May;26(5):1192-1202. doi: 10.1007/s12094-023-03342-y. Epub 2023 Nov 22.
Clin Transl Oncol. 2024.
PMID: 37989823